{"organizations": [], "uuid": "90cce2493ae64bdd07cf7719917bb42bb481e203", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-paladin-labs-announces-launch-of-n/brief-paladin-labs-announces-launch-of-new-indication-for-xiaflex-broadening-its-use-to-the-treatment-of-appropriate-patients-with-peyronies-disease-idUSFWN1S00NS", "country": "US", "domain_rank": 408, "title": "BRIEF-Paladin Labs Announces Launch Of New Indication For Xiaflex, Broadening Its Use To The Treatment Of Appropriate Patients With Peyronie's Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T14:39:00.000+03:00", "replies_count": 0, "uuid": "90cce2493ae64bdd07cf7719917bb42bb481e203"}, "author": "", "url": "https://www.reuters.com/article/brief-paladin-labs-announces-launch-of-n/brief-paladin-labs-announces-launch-of-new-indication-for-xiaflex-broadening-its-use-to-the-treatment-of-appropriate-patients-with-peyronies-disease-idUSFWN1S00NS", "ord_in_thread": 0, "title": "BRIEF-Paladin Labs Announces Launch Of New Indication For Xiaflex, Broadening Its Use To The Treatment Of Appropriate Patients With Peyronie's Disease", "locations": [], "entities": {"persons": [{"name": "xiaflex", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-paladin labs", "sentiment": "neutral"}, {"name": "endo international plc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "paladin labs inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News  40 AM / Updated 9 minutes ago BRIEF-Paladin Labs Announces Launch Of New Indication For Xiaflex, Broadening Its Use To The Treatment Of Appropriate Patients With Peyronie's Disease Reuters Staff 1 Min Read \nApril 23 (Reuters) - Endo International PLC: \n* PALADIN LABS INC. ANNOUNCES LAUNCH OF NEW INDICATION FOR XIAFLEX® (COLLAGENASE CLOSTRIDIUM HISTOLYTICUM), BROADENING ITS USE TO THE TREATMENT OF APPROPRIATE PATIENTS WITH PEYRONIE’S DISEASE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-23T14:39:00.000+03:00", "crawled": "2018-04-23T14:55:36.006+03:00", "highlightTitle": ""}